Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody
-
产品编号
YR1202
-
别名
科研级 Rovelizumab ( 罗维珠单抗 ), Anti-ITGAL & CD11a & CD18 Recombinant Antibody, Research Grade Rovelizumab
-
规格
- 1mg
- 5mg
产品介绍
| Catalog Number | YR1202 |
| Alias | 科研级 Rovelizumab ( 罗维珠单抗 ), Anti-ITGAL & CD11a & CD18 Recombinant Antibody, Research Grade Rovelizumab |
| Size | 1mg, 5mg |
| Molecular Name | Rovelizumab |
| CAS Number | 339086-79-2 |
| Target | ITGAL & CD11a & CD18[Homo sapiens] |
| Antibody Isotype | IgG4 |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. Rovelizumab was developed by Icos to treat patients suffering from haemorrhagic shock. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock. |
| Remarks | This product is for research use only. |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5栋
-
销售微信
-
官方公众号
-
400-621-6806 -
18630936064（微信同号） -
周一至周五 8:30-18:00 -
-
0
-
